JP2009511559A5 - - Google Patents

Download PDF

Info

Publication number
JP2009511559A5
JP2009511559A5 JP2008535097A JP2008535097A JP2009511559A5 JP 2009511559 A5 JP2009511559 A5 JP 2009511559A5 JP 2008535097 A JP2008535097 A JP 2008535097A JP 2008535097 A JP2008535097 A JP 2008535097A JP 2009511559 A5 JP2009511559 A5 JP 2009511559A5
Authority
JP
Japan
Prior art keywords
formula
represent
pharmaceutically acceptable
compound
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008535097A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009511559A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2006/003792 external-priority patent/WO2007042816A1/en
Publication of JP2009511559A publication Critical patent/JP2009511559A/ja
Publication of JP2009511559A5 publication Critical patent/JP2009511559A5/ja
Withdrawn legal-status Critical Current

Links

JP2008535097A 2005-10-12 2006-10-12 炎症の治療に有用なベンゾオキサゾール類 Withdrawn JP2009511559A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72530105P 2005-10-12 2005-10-12
PCT/GB2006/003792 WO2007042816A1 (en) 2005-10-12 2006-10-12 Benzoxazoles useful in the treatment of inflammation

Publications (2)

Publication Number Publication Date
JP2009511559A JP2009511559A (ja) 2009-03-19
JP2009511559A5 true JP2009511559A5 (cg-RX-API-DMAC7.html) 2009-12-03

Family

ID=36129701

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008535097A Withdrawn JP2009511559A (ja) 2005-10-12 2006-10-12 炎症の治療に有用なベンゾオキサゾール類

Country Status (5)

Country Link
US (1) US20090258917A1 (cg-RX-API-DMAC7.html)
EP (1) EP1933834A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009511559A (cg-RX-API-DMAC7.html)
CA (1) CA2620899A1 (cg-RX-API-DMAC7.html)
WO (1) WO2007042816A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080081913A1 (en) * 2006-09-29 2008-04-03 General Electric Company Benzoxazole and benzothiazole compounds and methods therefor
US20080081210A1 (en) 2006-09-29 2008-04-03 General Electric Company Authenticatable articles and methods therefor
US20100004301A1 (en) * 2006-12-14 2010-01-07 Benjamin Pelcman Benzoxazoles Useful in the Treatment of Inflammation
UY31322A1 (es) * 2007-09-05 2009-04-30 Amidas heterocíclicas y sus métodos de uso-975
WO2009080788A2 (en) * 2007-12-21 2009-07-02 Universite Catholique De Louvain Antibacterial agents
EP2078711A1 (en) 2007-12-28 2009-07-15 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. (Aza)indole derivative substituted in position 5, pharmaceutical composition comprising it, intermediate compounds and preparation process therefor
GB201006846D0 (en) 2010-04-23 2010-06-09 Glaxo Group Ltd Novel compounds
EP2495244A1 (en) 2011-03-02 2012-09-05 NovaSaid AB Piperidinyl benzoimidazole derivatives as mPGEs-1 inhibitors
CN105555756B (zh) 2013-06-28 2018-12-07 奥克兰联合服务有限公司 氨基酸缀合物和肽缀合物及缀合方法
EP3066089B1 (en) 2013-11-08 2019-11-06 Promentis Pharmaceuticals, Inc. Substituted n-acetyl-l-cysteine derivatives and related compounds
CA2971677A1 (en) 2014-12-23 2016-06-30 Margaret Anne Brimble Amino acid and peptide conjugates and uses thereof
CN104788398B (zh) * 2015-03-24 2017-09-08 上海交通大学 苯并恶唑类化合物及其制备方法和用途
TW201735952A (zh) 2016-02-26 2017-10-16 瑪格蕾特 安 布萊博 胺基酸及肽共軛物以及共軛過程
JP2024510435A (ja) 2021-03-18 2024-03-07 シージェン インコーポレイテッド 生体活性化合物の内部移行複合体からの選択的薬物放出

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298189A (en) * 1992-04-24 1994-03-29 Nanoptics Incorporated Proton transfer bis-benzazole fluors and their use in scintillator detectors
AU2003283597A1 (en) * 2002-11-16 2004-06-15 Oxford Glycosciences (Uk) Ltd Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors
WO2004080999A1 (en) * 2003-03-14 2004-09-23 Biolipox Ab Pyrazole compounds useful in the treatment of inflammation
JP2007516203A (ja) * 2003-07-09 2007-06-21 バイオリポックス エービー 炎症の治療に有用なインドール類
AU2004276337B2 (en) * 2003-09-24 2009-11-12 Methylgene Inc. Inhibitors of histone deacetylase
US20060052425A1 (en) * 2004-03-23 2006-03-09 Wisconsin Alumni Research Foundation Method for modulating microbial quorum sensing
CA2587489C (en) * 2004-11-03 2013-12-31 Curis, Inc. Mediators of hedgehog signaling pathways, compositions and uses related thereto

Similar Documents

Publication Publication Date Title
CA2475712C (en) Nicotinamide derivatives useful as pde4 inhibitors
RU2160257C2 (ru) Способ получения фенильных гетероциклов и промежуточное соединение
ES2604542T3 (es) Arilamidas con sustitución tetrazol
JP2022541483A5 (cg-RX-API-DMAC7.html)
RU2007101703A (ru) Индолы, полезные при лечении воспаления
CA2539909A1 (en) 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo(2,3-c) pyridin-2-ylmethyl) pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes
JP2005539054A5 (cg-RX-API-DMAC7.html)
JP2006520373A5 (cg-RX-API-DMAC7.html)
CN104981239A (zh) 硼酸衍生物及其治疗用途
CA2656415A1 (en) Novel pyridazine compound and use thereof
JP2005522449A (ja) Pde4阻害剤として有用なニコチンアミド誘導体
JP2010516701A5 (cg-RX-API-DMAC7.html)
RU2007101705A (ru) Индолы, полезные для лечения воспаления
JP2008502670A5 (cg-RX-API-DMAC7.html)
JP2023518775A5 (cg-RX-API-DMAC7.html)
JP2007522111A5 (cg-RX-API-DMAC7.html)
RU2013107759A (ru) Производные оксадиазола и пиридазина, их получение и применение в терапии
CN101300236A (zh) 作为脂肪加氧酶抑制剂的三唑化合物
JPH032173A (ja) 新規化合物、その製法及びそれを含む医薬組成物
JP2004517088A5 (cg-RX-API-DMAC7.html)
JP2005529084A (ja) 結晶性パレコキシブナトリウム
WO2014190899A1 (zh) 2,3-环氧丁二酰胺类化合物、其制备方法和用途
KR101536488B1 (ko) 이미다졸 유도체, 그의 제조 방법 및 용도
JP2009512670A (ja) 炎症の治療に有用なピラゾール化合物
JP2003532708A5 (cg-RX-API-DMAC7.html)